Введение. Коррекция факторов развития и прогрессирования неалкогольной жировой болезни печени (НАЖБП) у пациентов с сахарным диабетом 2-го типа (СД2) играет ключевую роль в снижении сердечно-сосудистых событий и неблагоприятных исходов.
Александр Олегович Поздняк +2 more
doaj +1 more source
[Efficacy of treatment with glucagon-like peptide receptor agonists-1 in Asian patients with type 2 diabetes mellitus]. [PDF]
Khamnueva LY, Andreeva LS.
europepmc +1 more source
[Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia]. [PDF]
Laptev DN +6 more
europepmc +1 more source
[Diabetic gastroenteropathy: modern methods of diagnosis and treatment]. [PDF]
Kuznetsov KO +9 more
europepmc +1 more source
[Use of metformin in patients with type 2 diabetes and acute myocardial infarction: safety and impact on glycemic control]. [PDF]
Korotina MA, Pochinka IG, Strongin LG.
europepmc +1 more source
[Synergistic effects of GABA and hypoglycemic drugs]. [PDF]
Tyurenkov IN +2 more
europepmc +1 more source
[Dysglycemia in COVID-19 and Type 2 Diabetes Mellitus: Peculiarities of the Glycemic Profile in Hospitalized Patients and the Role of Steroid-Induced Disorders]. [PDF]
Strongin LG +4 more
europepmc +1 more source
[Diabetes mellitus and the female reproductive system tumors]. [PDF]
Sharafutdinova KI +7 more
europepmc +1 more source
[Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the ACE2 gene, and therapy with RAS blockers on the severity of COVID-19]. [PDF]
Zuraeva ZT +8 more
europepmc +1 more source
[The ketogenic diet: history, mechanism of action, indications and contraindications]. [PDF]
Ivannikova EV +2 more
europepmc +1 more source

